Joy J Goto

Title: Joy J Goto: Innovator in ALS Research

Introduction

Joy J Goto is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of amyotrophic lateral sclerosis (ALS) research. His work focuses on the modulation of radical formation through mutant CuZnSOD enzymes, which are associated with familial ALS.

Latest Patents

Joy J Goto holds a patent for a method of modulating radical formation by mutant CuZnSOD enzymes. This patent addresses the discovery that familial amyotrophic lateral sclerosis (FALS)-associated mutant CuZnSODs, specifically A4V and G93A, catalyze the generation of hydroxyl radicals from hydrogen peroxide at higher rates than the wild type CuZnSOD. The research indicates that the copper chelator diethyldithiocarbamate (DDC) inhibits both radical generation and SOD activity of these mutant enzymes at significantly lower concentrations than required for the wild type. In neural cell culture models of FALS, DDC reverses the effects of four FALS-associated mutants without altering the survival of cells expressing only the wild type CuZnSOD. This suggests that radical formation can be modulated and ALS treated in subjects with a mutant CuZnSOD enzyme through the administration of copper chelating agents and radical scavenging agents.

Career Highlights

Joy J Goto has worked with prestigious institutions such as the University of California and The Burnham Institute. His research has contributed to a deeper understanding of ALS and potential treatment methods.

Collaborations

Joy has collaborated with notable colleagues, including Martina Wiedau-Pazos and Dale E Bredesen. Their combined efforts have advanced the research in the field of ALS.

Conclusion

Joy J Goto's innovative work in ALS research highlights the potential for new treatment strategies through the modulation of radical formation. His contributions are paving the way for future advancements in understanding and treating this challenging disease.